CCL18: a potential immunosuppressive biomarker for prognosis in ABC diffuse large B-cell lymphoma
Identification
- Clé publique
- radar:r-385a391644e36150bce52841ffcd11fa
- Auteurs
- Marta Rodríguez · Francisco Rojas-Vega · Jesús Frutos Dıáz-Alejo · Ignacio Mahíllo · Cristina Serrano · Alberto López García · Teresa Morales‐Ruíz · Teresa Roldán‐Arjona · Joaquín Sánchez‐García · Ana Rio‐Machín · Daniel Morillo · María Ángeles Rodríguez Pérez · Raúl Córdoba · Pilar Llamas · Socorro Marıá Rodríguez-Pinilla · Juana Serrano‐López
- Année déclarée
- 2025
- Langue déclarée
- en
- Type source
- article
- Première détection
- 2026-11-14T02:15:29.429644+00:00
- Dernière observation des métadonnées
- 2026-11-14T02:15:29.429644+00:00
- Dernière vérification HTTP
- Non effectuée
Institutions déclarées par la source
Hospital Universitario Fundación Jiménez Díaz · Instituto Maimónides de Investigación Biomédica de Córdoba · Hospital Universitario Reina Sofía · University of Córdoba · Instituto de Investigación Sanitaria Fundación Jiménez Díaz · Universidad Autónoma de Madrid · Queen Mary University of London · Barts Cancer Institute · Universidad Alfonso X el Sabio
Pays d’affiliation déclarés
ES · GB
Résumé documentaire — langue originale
Background Activated B-cell (ABC) diffuse large B-cell lymphoma (DLBCL) has worse outcomes than the germinal center B-cell (GCB) subtype, but underlying molecular mechanisms remain poorly understood. Methods Transcriptomic analysis on 43 DLBCL samples (23 GCB and 20 ABC) was performed using NanoString PanCancer Immune Profiling Panel with 30 cell-of-origin genes. Tumor microenvironment characterization was performed using CIBERSORTx and gene set enrichment analysis (GSEA) deconvolution. Based on our previous findings of MAPK10 downregulation in ABC lymphomas, MAPK10 promoter methylation was studied via pyrosequencing. Prognostic biomarkers were identified using the Cox regression and least absolute shrinkage and selection operator (LASSO) regularization. Therapeutic candidates were identified through connectivity mapping. Results ABC lymphomas showed distinct profiles with the overexpression of VTCN1 , CDK4 , and CXCR5 and the downregulation of MMP9 and MAPK10 . GSEA revealed enrichment of inflammatory pathways with immunosuppressive signals in ABC cases. Confirming our prior observations, MAPK10 downregulation in ABC tumors was associated with promoter hypermethylation and inferior overall survival ( p < 0.01). Immune deconvolution revealed greater microenvironmental diversity in ABC cases with significant eosinophil enrichment. High CD8 + T-cell abundance was associated with improved survival, particularly in ABC patients ( p < 0.01). Multivariate analysis identified CCL18 as an independent adverse prognostic factor (HR: 1.87, 95% CI: 1.25–2.79, p < 0.01). Connectivity mapping identified proteasome inhibitors and CDK4/6 inhibitors as promising therapeutic candidates. Conclusions We validated MAPK10 promoter hypermethylation and CCL18 overexpression as prognostic biomarkers in ABC DLBCL. These findings, derived from integrative transcriptomic and immunogenomic profiling, provide clinically relevant insights into disease biology and support biomarker-guided strategies for precision treatment in aggressive B-cell lymphomas.
Identifiants
- OPENALEX
- https://openalex.org/W4417312536
- DOI
- 10.3389/fimmu.2025.1693730
- PMID
- https://pubmed.ncbi.nlm.nih.gov/41472741
- PMCID
- https://www.ncbi.nlm.nih.gov/pmc/articles/12745396
Repères documentaires
- Famille documentaire
- article
- Types déclarés par les sources
- article
- Éditeurs
- Frontiers Media
Les mentions d’entités ne constituent pas une preuve de reconnaissance juridique. La juridiction étudiée est distincte du pays d’affiliation des auteurs.
Sources
OpenAlex · Document 1
Citer cette référence
Marta Rodríguez; Francisco Rojas-Vega; Jesús Frutos Dıáz-Alejo; Ignacio Mahíllo; Cristina Serrano; Alberto López García; Teresa Morales‐Ruíz; Teresa Roldán‐Arjona; Joaquín Sánchez‐García; Ana Rio‐Machín; Daniel Morillo; María Ángeles Rodríguez Pérez; Raúl Córdoba; Pilar Llamas; Socorro Marıá Rodríguez-Pinilla; Juana Serrano‐López. CCL18: a potential immunosuppressive biomarker for prognosis in ABC diffuse large B-cell lymphoma. 2025. https://doi.org/10.3389/fimmu.2025.1693730
JSON · CSL-JSON · BibTeX · RIS · CSV · JSON-LD ·
APA, Chicago, ISO 690 : formats bibliographiques fondés sur les champs disponibles. OSCOLA / Bluebook : données structurées uniquement ; aucune conformité juridique complète n’est revendiquée sans vérification des éléments nécessaires.
- APA
- Marta Rodríguez; Francisco Rojas-Vega; Jesús Frutos Dıáz-Alejo; Ignacio Mahíllo; Cristina Serrano; Alberto López García; Teresa Morales‐Ruíz; Teresa Roldán‐Arjona; Joaquín Sánchez‐García; Ana Rio‐Machín; Daniel Morillo; María Ángeles Rodríguez Pérez; Raúl Córdoba; Pilar Llamas; Socorro Marıá Rodríguez-Pinilla; Juana Serrano‐López. (2025). CCL18: a potential immunosuppressive biomarker for prognosis in ABC diffuse large B-cell lymphoma. https://doi.org/10.3389/fimmu.2025.1693730
- Chicago
- Marta Rodríguez; Francisco Rojas-Vega; Jesús Frutos Dıáz-Alejo; Ignacio Mahíllo; Cristina Serrano; Alberto López García; Teresa Morales‐Ruíz; Teresa Roldán‐Arjona; Joaquín Sánchez‐García; Ana Rio‐Machín; Daniel Morillo; María Ángeles Rodríguez Pérez; Raúl Córdoba; Pilar Llamas; Socorro Marıá Rodríguez-Pinilla; Juana Serrano‐López. CCL18: a potential immunosuppressive biomarker for prognosis in ABC diffuse large B-cell lymphoma. 2025. https://doi.org/10.3389/fimmu.2025.1693730
- ISO 690
- Marta Rodríguez; Francisco Rojas-Vega; Jesús Frutos Dıáz-Alejo; Ignacio Mahíllo; Cristina Serrano; Alberto López García; Teresa Morales‐Ruíz; Teresa Roldán‐Arjona; Joaquín Sánchez‐García; Ana Rio‐Machín; Daniel Morillo; María Ángeles Rodríguez Pérez; Raúl Córdoba; Pilar Llamas; Socorro Marıá Rodríguez-Pinilla; Juana Serrano‐López. CCL18: a potential immunosuppressive biomarker for prognosis in ABC diffuse large B-cell lymphoma. 2025. https://doi.org/10.3389/fimmu.2025.1693730
Warning: Undefined array key "last_link_verified" in /home/clients/e27d81e12f04d2bfd747aa264540ac56/sites/_UDTR_APP/legal_library_reference.php on line 31
UDTR — Bibliothèque juridique mondiale des droits de la Nature. CCL18: a potential immunosuppressive biomarker for prognosis in ABC diffuse large B-cell lymphoma. Notice documentaire: https://www.declarationuniverselledesdroitsdelarbre.org/global-rights-of-nature-radar/reference/r-385a391644e36150bce52841ffcd11fa/ · Dernière vérification HTTP : non effectuée
Données de cette version figée
Dossiers et relations documentaires
Rôles des sources
Source bibliographique / publication d’origine · https://doi.org/10.3389/fimmu.2025.1693730
Un lien vers une autorité ne prouve pas à lui seul une affirmation juridique. Les résumés et les textes intégraux restent soumis aux conditions de leur source.
Statut documentaire
Pertinence à examiner
Bibliothèque
Cette identité n’est pas encore intégrée à la Bibliothèque juridique.